T1	Intervention 818 899	1) Defibrotide at a dose of 400 mg b.i.d. i.v. in 50 ml phleboclysis in 5 minutes
T2	Intervention 911 972	2) calcium heparin at a dose of 5000 IU t.i.d. subcutaneously
T3	Intervention 984 1262	The treatment began the day before operation and continued on average up to the eighth day for the Defibrotide group. With the control group it continued until discharge (usually on the 15th day) and at home for about three weeks until the completion of the physiotherapy cycle.
